3rd Quarter - Report

JAZZ PHARMACEUTICALS, INC. for JAZZ PHARMACEUTICALS, INC.

Firm
Client
Income
—
Expenses
$490,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Pharmacy PHA

H.R. 1996 - SAFE Banking Act of 2021 Issues related to the regulation of cannabis and CBD, research and development of cannabis-derived therapies Provisions related to patient safety, CBD product regulations, and FDA regulation and enforcement FDA regulation of cannabis derived products

LobbyistCovered position, as disclosed
KARAS GROSS —
VIRGINIA MCMILLIN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: H.R. 1996 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.